Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Calvert

Showing results (111-120 of 220) with videos related to

Pageof 22
Sort By:
Cancer Research|April 1, 1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal functionS J Harland, D R Newell, Z H Siddik, et al.
Current Medicinal Chemistry|July 14, 2012
Synthetic lethality to overcome cancer drug resistanceL Porcelli, A E Quatrale, P Mantuano, et al.
Journal of Medicinal Chemistry|June 12, 1992
Quinazoline antifolate thymidylate synthase inhibitors: difluoro-substituted benzene ring analoguesT J Thornton, A L Jackman, P R Marsham, et al.
Cancer Research|February 1, 1992
Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation schemeM A Graham, D R Newell, B J Foster, et al.
Journal of Environmental Quality|April 28, 2011
Influence of aeration implements, phosphorus fertilizers, and soil taxa on phosphorus losses from grasslandsD H Franklin, D M Butler, M L Cabrera, et al.
Molecular Pharmacology|February 1, 1994
A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogsP C Sanghani, A Jackman, V R Evans, et al.
Cancer Research|September 1, 1990
Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivoA L Jackman, G A Taylor, B M O'Connor, et al.
Melanoma Research|April 4, 2002
Effect of temozolomide on central nervous system relapse in patients with advanced melanomaM J Paul, Y Summers, A H Calvert, et al.
British Journal of Cancer|February 1, 1991
Phase II trial of trimelamol in refractory ovarian cancerI R Judson, A H Calvert, M E Gore, et al.
Biochimie|January 1, 1995
The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapyR J Griffin, N J Curtin, D R Newell, et al.
Pageof 22

Showing results (111-120 of 220) with videos related to

Sort By:
Pageof 22
Cancer Research|April 1, 1984
Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal functionS J Harland, D R Newell, Z H Siddik, et al.
Current Medicinal Chemistry|July 14, 2012
Synthetic lethality to overcome cancer drug resistanceL Porcelli, A E Quatrale, P Mantuano, et al.
Journal of Medicinal Chemistry|June 12, 1992
Quinazoline antifolate thymidylate synthase inhibitors: difluoro-substituted benzene ring analoguesT J Thornton, A L Jackman, P R Marsham, et al.
Cancer Research|February 1, 1992
Clinical pharmacokinetics of the anthrapyrazole CI-941: factors compromising the implementation of a pharmacokinetically guided dose escalation schemeM A Graham, D R Newell, B J Foster, et al.
Journal of Environmental Quality|April 28, 2011
Influence of aeration implements, phosphorus fertilizers, and soil taxa on phosphorus losses from grasslandsD H Franklin, D M Butler, M L Cabrera, et al.
Molecular Pharmacology|February 1, 1994
A strategy for the design of membrane-permeable folypoly-gamma-glutamate synthetase inhibitors: "bay-region"-substituted 2-desamino-2-methyl-5,8-dideazafolate analogsP C Sanghani, A Jackman, V R Evans, et al.
Cancer Research|September 1, 1990
Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivoA L Jackman, G A Taylor, B M O'Connor, et al.
Melanoma Research|April 4, 2002
Effect of temozolomide on central nervous system relapse in patients with advanced melanomaM J Paul, Y Summers, A H Calvert, et al.
British Journal of Cancer|February 1, 1991
Phase II trial of trimelamol in refractory ovarian cancerI R Judson, A H Calvert, M E Gore, et al.
Biochimie|January 1, 1995
The role of inhibitors of poly(ADP-ribose) polymerase as resistance-modifying agents in cancer therapyR J Griffin, N J Curtin, D R Newell, et al.
Pageof 22